We are hiring a technician / laboratory manager: linkedin.com/feed/update/ur…

PORTFOLIO/ Timothy Lu (head of synthetic biology at M.I.T.) just accepted to join #pulmobiotics board of directors. His talent will not only be a boost for the company but for our biotech ecosystem as well, it's a pleasure & a privilege to work with him @InvivoCapital Centre for Genomic Regulation (CRG)

Pulmobiotics S.L welcomes synthetic biology pioneer Timothy Lu (Head of Synthetic Biology group at M.I.T.) as an Independent Board Director.

🦠💊 Crean una 'píldora viva' para tratar infecciones resistentes a antibióticos. El hallazgo de Centre for Genomic Regulation (CRG), con apoyo #CaixaResearchFundlaCaixa, es un gran paso en el desarrollo de tratamientos para las infecciones que afectan a los implantes médicos. agenciasinc.es/Noticias/Crean…

Pulmobiotics is looking for a PhD-educated Scientist with expertise in animal work. If you are interested in working in a biotech company developing "living pills" for the treatment of respiratory diseases, get in touch! linkedin.com/feed/update/ur…

We are hiring a Technician / Lab manager to start in October! linkedin.com/feed/update/ur…

Pulmobiotics receives 1.9m euros to develop ‘living medicine’ for lung cancer. lnkd.in/dFBq3kJ7

📰 Pulmobiotics SL, #spinoff del Centre for Genomic Regulation (CRG), obtiene 1,9 M de euros del Consejo Europeo de Innovación (European Innovation Council). El objetivo es continuar con el desarrollo de una píldora viva para el tratamiento del #cáncer de pulmón. 👇En @expansion

#VentureCapital: Pulmobiotics SL, participada por @InvivoCapital, recibe €1,9M para desarrollar una píldora viva para el cáncer de pulmón webcapitalriesgo.com/pulmobiotics-p…

‼️ Pulmobiotics, a start-up founded at the CRG, has received 1.9 million euros from the European Innovation Council to develop ‘living medicine’ to improve the efficacy of lung cancer treatment 📷 Pulmobiotics SL team 🔗bit.ly/3FthJcR

#Inversiones💰 Pulmobiotics SL obtiene 1,9M€ para desarrollar un nuevo tratamiento contra el cáncer de pulmón 👏🏻 elreferente.es/inversiones/pu…

Impulso a la ‘píldora viva’ contra el cáncer de pulmón Pulmobiotics SL Centre for Genomic Regulation (CRG) saludadiario.es/investigacion/…

📚 ‘Living medicine’ created to tackle drug-resistant lung infections The treatment involves using a modified version of the bacterium Mycoplasma pneumoniae, removing its ability to cause disease and repurposing it to attack P. aeruginosa instead.

Engineered live bacteria suppress 𝘗𝘴𝘦𝘶𝘥𝘰𝘮𝘰𝘯𝘢𝘴 𝘢𝘦𝘳𝘶𝘨𝘪𝘯𝘰𝘴𝘢 infection in mouse lung and dissolve endotracheal-tube biofilms go.nature.com/3QTnJAZ

Centre for Genomic Regulation (CRG) Pulmobiotics SL Instituto de Agrobiotecnología - CSIC IDIBAPS Universitat de Barcelona VISAVET-UCM ‘Living medicine’ created to tackle drug-resistant lung infections #NBTintheNews via Centre for Genomic Regulation (CRG) crg.eu/en/news/living…

María LLuch y Luis Serrano de Centre for Genomic Regulation (CRG) y Pulmobiotics SL, investigadores #CaixaResearch, han comprobado que esta bacteria modificada genéticamente 🫁 es capaz de llegar al pulmón 🐭 y logra duplicar la tasa de supervivencia en ratones con una sola dosis

Newco news: Pulmobiotics SL is developing cell therapy for lung diseases, but with a twist bioworld.com/articles/69347… #biotech #pharma